NCT07216482View on ClinicalTrials.gov

A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

975

Participants

Timeline

Start Date

November 19, 2025

Primary Completion Date

December 2, 2026

Study Completion Date

March 1, 2027

Conditions

Hyperlipidemia

Interventions

DRUG

Enlicitide

Oral Tablet

DRUG

Rosuvastatin

Oral Capsule

DRUG

Placebo for Enlicitide

Oral Tablet

DRUG

Placebo for Rosuvastatin

Oral Capsule

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY